Arrowhead Research | ARWR - DEBITO





DEBITO Cambiamento Data
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 983.69M 5.77M 2026-06
Heron Therapeutics USD 149.65M 157K 2024-09
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Ligand Pharmaceuticals USD 451.98M 486K 2026-03
Merck USD 49.12B 222M 2026-03
Moderna USD 1.3B 7M 2026-03
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 49.01B 2.02B 2026-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
TG Therapeutics USD 754.44M 884K 2026-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06
Xencor USD 175.16M 12.58M 2026-03